Mish's Global Economic Trend Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Webster Groves who wrote (100505)	8/7/2009 8:19:12 AM
From: skinowski	2 Recommendations Read Replies (4) of 116555

if you're in the field for a while, it's likely that as many as 8 out of 10 meds you write were developed already after you're out of training. Getting familiar - and comfortable - with those new meds is a complex process. You read the Medical Letter and a multitude of other sources, you buttonole specialists who have experience in using them, you listen to lectures, etc. Inter alia, you also talk to drug reps who often tend to be quite knowledgeable. I like to ask reps about the downsides of their competition's products (g). Heck, a few times I even went to internet chat rooms where people using those new meds talk about them. In my case, haven't see salmon and pilaf for some time now, but admit to consuming a couple of Panera Bread soup&sandwiches in recent months. I'm not saying this doesn't happen... I'm just not under the impression that it's a very big issue. I think it would be demagoguery if they outlaw it (do they outlaw politicians breaking bread with lobbyists?).... but if they do, most docs wouldn't shed tears.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next